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outpatient procedures. Cost savings are assumed, but published data on the subject are
scarce. The aim of this study was to retrospectively determine the possible cost savings
achieved by performing reduction mammaplasties as outpatient procedures.
Material and methods: Reduction mammaplasty was performed for 90 outpatients and 44 in-
patients, with comparable health status. Demographic, surgical, and complication data were
collected retrospectively. Data on the costs of the entire treatment process were acquired
and statistical analyses performed.
Results: Theaverage total costof theprocesswas5039V for inpatientsand4114V foroutpatients.
Thus, the total costswere 925V (18%) lower for theoutpatientprocedures.Onaverage, cost saving
per patient was 294V (43%) onward expenditures. Higherward expenditurewas a statistically sig-
nificant cause of the increased cost of the inpatient group on uni- andmultivariable analyses; how-
ever, for total costs, the effects of complications and reoperations were significant.
Conclusions: Reduction mammaplasty performed as an outpatient procedure results in up to 18%
cost savings compared with inpatient treatment.
ª 2016 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier
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Plastic, Reconstructive and AesthetiIntroduction
Although it is often assumed that outpatient procedures are
less expensive than inpatient procedures, published reports
on the subject are scarce. Costs involved in cataract sur-
gery have been shown to be 20% higher for inpatients.1 Day
case surgery for Dupuytren’s contracture has been shown to
be associated with 18% cost savings compared withc Surgeons. Published by Elsevier Ltd. All rights reserved.
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mastectomy performed as outpatient procedures have
been shown to result in cost savings of 75e78% compared
with 2 or 3 days of hospitalization.3
To the best of our knowledge, studies specifically
addressing the costs of outpatient reduction mamma-
plasties have not been published yet, although the issue
has been briefly discussed in few previous articles. Bue-
naventura et al.4 reported cost savings of US $1500e2500
(25e35%) per patient, but this was based on estimated
average costs of a reduction mammaplasty surgery in
different facilities and not on direct calculations at the
level of specific patients. Davies et al.5 reported cost
savings of 40e50% compared with the average costs of
outpatient (n Z 20) and inpatient (n Z 20) procedures,
but without specifying the parameters included in the
costs (except for excluding surgeon’s fee). Short et al.6
found that outpatient procedures are 30% less expen-
sive than surgeries with a one-night hospital stay,
although for longer stays the difference was even higher.
However, in their study, the groups were not similar: the
inpatients weighed more and had more complications,
possibly increasing the costs of treatment. In addition,
they did not specify the components of their cost anal-
ysis. Nelson et al.7 reported on practice profiles of Ca-
nadian plastic surgeons in reducing breast size. They
mentioned that the day surgery fee was US $300 and the
cost of a 24-h ward admission was US $1173, resulting in
a cost saving of 75%.
In the evaluation of the possible cost benefits of
outpatient surgery, a number of different cost parameters
have to be taken into account. In addition to the surgical
procedure and stay in the outpatient unit or overnight in
the hospital ward, the costs of pre- and postoperative
planned and unplanned visits to the clinic and possible
readmissions and reoperations have to be considered. This
will reflect almost the costs of the entire process of surgical
treatment of breast hypertrophy as an outpatient or inpa-
tient procedure.
Outpatient breast reduction procedures were started in
our university hospital outpatient unit in 2006. The purpose
of this study was to evaluate the possible cost savings
achieved by this change in practice.Material and methods
Reduction mammaplasty patient records obtained from
our university hospital outpatient unit were examined.
The retrospective study covered a period between
September 2006 and May 2009. Inclusion criteria were
bilateral mammaplasties by either pedicled technique or
free nipple grafting with the minimum resection weight
of 400 g. Procedures done on males for gynecomastia
were excluded from the study. During the study period,
some of the patients who were originally selected to
have an outpatient procedure were reassigned to be
treated as inpatients for nonclinical reasons (e.g., wait-
ing time for an outpatient surgery exceeding 6 months).
These patients were then allocated to the inpatient
comparison group. Patients who were operated in the
operating room of the outpatient unit and admittedovernight for social reasons (no adult to accompany the
patient for the first 24 h postoperatively) were also
transferred to the inpatient comparison group.
Medical records of all the eligible patients were
reviewed and relevant demographic and surgical informa-
tion were collected. All complications, reoperations, and
unexpected hospital admissions and return visits together
with their reasons were recorded. Complications were
further defined as minor and major. Minor complications
included delayed healing, superficial infections, and sero-
mas, whereas major complications included wound dehis-
cence of >2 cm lasting for >4 weeks after the surgery,
hematomas that required evacuation, deep infections
requiring drainage or intravenous antibiotics, and nipple or
fat necrosis.
In our university hospital, information about all costs
of hospital treatment of individual patients are routinely
stored in Ecomed clinical patient administration data-
base (Datawell Ltd., Espoo, Finland). In order to include
all costs of the treatment process, data of each patient
from the database were viewed from 12 months before
the date of surgery to 18 months postoperatively. Data
of all costs relating to the treatment of breast hyper-
trophy or possible postoperative complications were
collected.
Statistical analysis was performed with SPSS Statistics
version 22.0 and R version 2.15.3. Chi square test, Fisher’s
exact test, and independent sample T-test were performed
for univariate analysis as appropriate for each variable. A
general linear model was built for univariate analysis be-
tween group effects. A multivariate analysis of variance
(MANOVA) was performed to define demographic or surgical
variables correlated with total cost, procedural cost, and
ward expenditure. Statistical significance was set at
p < 0.05.Results
During the study period, 90 patients were treated as out-
patients and 44 as inpatients. The demographic data as well
as type of surgery performed were similar in the outpatient
and inpatient groups (Table 1). Drains and prophylactic
anticoagulant therapy were used more often in the inpa-
tient group. The complication rate was higher for the in-
patients and they also needed additional visits to dressing
clinic and emergency polyclinic (Table 2).
The average total costs of the treatment process for the
outpatients and inpatients were 4114 and 5039 V, respec-
tively, with the difference being statistically significant
(p Z 0.036). The maximum difference between the groups
was in ward expenditure, but the costs were higher for the
inpatients in all of the recorded cost categories (Table 3).
The most expensive part of the process was the surgical
procedure, including theater time. The general linear
model showed that treatment group was a statistically
significant reason for higher ward expenditures (pZ 0.01),
but not total expenditure (p Z 0.082) or procedural cost
(p Z 0.091). Multivariate analysis showed a significant
correlation between expenditures and treatment group
(p Z 0.014, Wilk’s lambda 0.912), emergency room (ER)
visit (p Z 0.001, Wilk’s lambda 0.873), additional wound
Table 1 Demographic and surgical information of the outpatient and inpatient groups.
Variable Outpatients Inpatients p
Mean age, years (range) 43 (16e67) 44 (18e69) ns
Mean body mass index (BMI), kg/m2 (range) 27 (20e37) 28 (20e37) ns
Smokers, n (%) 15 (17) 9 (20) ns
Previous medical condition, n (%)a 47 (52) 26 (59) ns
Mean operative time, min (range) 164 (99e259) 162 (99e228) ns
Mean weight of tissue resected, g (range) 1150 (400e3119) 1312 (403e3142) ns
Mean perioperative bleeding, ml (range) 176 (50e550) 249 (50e800) 0.005
Use of drains, n (%) 17 (19) 26 (59) <0.00001
Use of prophylactic anticoagulant therapy, n (%) 3 (3) 19 (43) <0.00001
Operating surgeon a resident in training, n (%) 14 (16) 13 (30) ns
Procedure type, n (%) ns
Pedicular nipple transposition 82 (91) 40 (90)
Free nipple graft 3 (3) 2 (5)
Pedicular nipple transposition and liposuction 5 (6) 2 (5)
Incision, n (%) ns
Inverted T 49 (54) 24 (55)
Vertical 41 (46) 20 (45)
a Previous medical condition refers to any illness or disease other than breast hypertrophy.
1488 A. Carpelan, S. Kauhanentreatment (p Z 0.004, Wilk’s lambda 0.892), immediate
reoperation (p < 0.001, Wilk’s lambda 0.545), and late
reoperation (p < 0.001, Wilk’s lambda 0.847).Discussion
In this study, outpatient reduction mammaplasty pro-
cedures were associated with significantly lower costs
than inpatient procedures. Total costs were 925 V (18%)
lower for the outpatient procedures. On average, ward
expenditure of 294 V (43%) per patient was saved. The
savings were not as high as previously reported,4e7 which
might have been due to several reasons. For example,
our multivariate analysis showed that in addition to
treatment group, costs correlated closely with ER visits
and additional wound treatments as well as reoperations.
Previous studies have not included these additional orTable 2 Complications and revisits.
Variable Outpatients Inpatients p
ER visits n (%) 15 (17) 14 (32) 0.046
Dressing clinic n (%) 17 (19) 16 (36) 0.027
Complications n (%) 0.026
Minor 38 (42) 24 (55)
Major 13 (14) 10 (23)
No 39 (43) 10 (23)
Immediate reoperations n (%) ns
Hematoma evacuation 5 (6) 1 (2)
Revision for infection 1 (1) 1 (2)
Late reoperations n (%) ns
Dog ear excision 20 (22) 12 (27)
Other 12 (13) 9 (20)later costs. As complications are more and their treat-
ments are expensive,8 this may account for much of our
difference with previous studies. Moreover, all of the
previous studies are from the United States and Canada,
and therefore there will have been differences in the
pricing of surgical procedures and ward expenditure from
those of Europe and Finland.
For the inpatient treatment group, higher ward ex-
penditures were a statistically significant cause for the
higher costs of treatment, but for total costs, the
sequelae of major complications played a significant role
when the entire treatment process is included in the
analysis. In particular, reoperations (theater time) and
prolonged hospital stays were expensive. The number of
complications was higher in the inpatient group, which
increased the cost difference between the treatment
groups. In our previous study, where we analyzed the
complication profile of outpatient reduction mamma-
plasty patients,9 only longer operative time correlated
with an increasing number and severity of complications.Table 3 Average costs.
Variable Outpatients Inpatients p
Total cost (V) 4114 5039 0.036
Clinic costs (V) 583 685 ns
Cost of the procedure (V) 2307 2658 ns
Ward expenditure (V) 390 684 0.001
Laboratory tests (V) 65 79 ns
Pathology (V) 397 414 ns
Clinical procedures (V) 270 400 ns
Radiology (V) 101 118 ns
Unspecified (V) 1 1,59 ns
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between patients operated by residents or certified
plastic surgeons. In this study, the operative times of
outpatients and inpatients were similar, but inpatients
seemed to be more often operated by residents, although
the difference was not statistically significant. Drains
were seldom used for outpatients. Removal of drains is
difficult to arrange once the patient is discharged. For
inpatients, drains were used more often, and it is
possible that they have acted as routes for contamination
and infection, thus increasing the amount of complica-
tions. The risk of thromboembolic events was considered
higher for the inpatients resting at their hospital beds
and thus prophylactic anticoagulant therapy was used
more often for inpatients. This might have resulted in
more bleeding and thus more hematomas and wound in-
fections. Reduction mammaplasty is a procedure with a
rather high (40e50%) complication rate10e12 and the
complication rate in our study population was similar to
that previously reported. Fortunately, most of the com-
plications were minor, but the costs of their treatment
are an inevitable part of the expenditure of surgical
treatment of breast hypertrophy. In spite of these addi-
tional costs, the cost utility of reduction mammaplasty is
high, as expressed by the quality-adjusted life years
gained by the assets invested in the treatment process.13
The cost utility can be further increased with the savings
achieved by outpatient treatment.
The major limitations of this study are its retrospective
nature and the small sample size. On the contrary, as a
retrospective study, we believe that it reflects the true
costs in our outpatient and inpatient units. In spite of the
limitations, we also believe that our study suggests that
outpatient mammaplasty is cheaper than inpatient mam-
maplasty. On the basis of this study, we feel that outpatient
reduction mammaplasty should be adopted more widely in
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